Schedule a meeting with us!

por Asphalion

4 years ago
meeting, drug, regulatory affairs

Are you developing a drug and need help with regulatory affairs?

Next Stop, the Clinic - Preparing your new Drug for Clinical Research with SciFindern and Formulus®

por CAS, a division of the American Chemical Society

4 years ago
webinar, Drug, Clinical Research, SciFindern, Formulus, webinar

Things are going well for your latest drug molecule - it seems efficacious, you have assessed potential toxicity, and even determined a safe starting dose, and now you are ready to move to the clinic...

FreeOx acquires the patent for the drug Ox-01 in the US for ischaemic stroke

por CataloniaBio

4 years ago
FreeOx, patent, ischaemic stroke, thrombectomy, drug

FreeOx Biotech, a CataloniaBio & HealthTech member, has been granted a patent for its most advanced drug, Ox-01, by the United States Patent and Trademark Office (USPTO). The patent protects the use o...

Promega Developing OncoMate™ MSI Assay as Companion Diagnostic for Endometrial Cancer Drug Candidate from Incyte

por Promega Biotech Ibérica

4 years ago
OncoMate, MSI, Endometrial Cancer, drug, retifanlimab

Promega Corporation announced today its intent to develop the Promega OncoMate™ microsatellite instability (MSI) Assay as a companion diagnostic test for retifanlimab, Incyte’s anti-PD-1 drug cand...

Palobiofarma announces positive results from the Phase II clinical trial evaluating the preliminary efficacy and safety of its adenosine A1 receptor antagonist PBF-680 in mild to moderate asthmatics patients

por Palobiofarma

4 years ago
drug, asthmatics, clinical trial

The results confirm a clinically and statistically significant improvement in trough FEV1 of asthmatic patients taking 10mg of PBF-680 for 14 days compared to placebo.

Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis

por Galchimia

4 years ago
visceral leishmaniasis, GlaxoSmithKline, treatments, drug

We are happy to share our latest report from the work carried out in collaboration with GlaxoSmithKline and the Drug Discovery Unit of the University of Dundee. The paper published in RSC Medicinal Ch...

Minoryx Therapeutics receives US FDA fast-track designation for leriglitazone in the treatment of X-ALD

por Minoryx Therapeutics

5 years ago
Friedreich’s Ataxia, drug, Central Nervous System, neuroscience

Leriglitazone (MIN-102), a novel, brain penetrant, orally bioavailable and selective PPARγ agonist, is currently in late-stage development for treatment of severe orphan CNS disorders, including X-AL...

FDA aims to start deactivating outdated drug listing records to ensure the patient safety

por Asphalion

5 years ago
FDA, drug, patient safety

The Food and Drug Administration (FDA) announced its intention to clean the drug listing database from outdated and uncertified records. This action is not limited only to listings for finished drug p...